These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2711157

  • 41. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
    Price RI, Gutteridge DH, Stuckey BG, Kent GN, Retallack RW, Prince RL, Bhagat CI, Johnston CA, Nicholson GC, Stewart GO.
    J Bone Miner Res; 1993 Feb; 8(2):209-17. PubMed ID: 8442439
    [Abstract] [Full Text] [Related]

  • 42. Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.
    Gutteridge DH, Ward LC, Stewart GO, Retallack RW, Will RK, Prince RL, Criddle A, Bhagat CI, Stuckey BG, Price RI, Kent GN, Faulkner DL, Geelhoed E, Gan SK, Vasikaran S.
    J Bone Miner Res; 1999 Oct; 14 Suppl 2():79-84. PubMed ID: 10510219
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA.
    Henry Ford Hosp Med J; 1983 Oct; 31(4):244-8. PubMed ID: 6425243
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
    Devlin RD, Retallack RW, Fenton AJ, Grill V, Gutteridge DH, Kent GN, Prince RL, Worth GK.
    J Bone Miner Res; 1994 Jan; 9(1):81-5. PubMed ID: 8154313
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE, Frölich M.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [Abstract] [Full Text] [Related]

  • 49. [Bisphosphonate therapy of Paget's disease of bone with pamidronate].
    Grauer A, Klar B, Knaus J, Scharla SH, Ziegler R.
    Med Klin (Munich); 1996 Jan 15; 91(1):14-9. PubMed ID: 8839196
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
    Stewart GO, Gutteridge DH, Price RI, Ward L, Retallack RW, Prince RL, Stuckey BG, Kent GN, Bhagat CI, Dhaliwal SS.
    Bone; 1999 Feb 15; 24(2):139-44. PubMed ID: 9951784
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A, Klar B, Scharla SH, Zieglar R.
    Semin Arthritis Rheum; 1994 Feb 15; 23(4):283-4. PubMed ID: 8009261
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L, Kuntz D.
    Rev Rhum Mal Osteoartic; 1989 Mar 15; 56(4):287-92. PubMed ID: 2496460
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.